Position in NAGE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$267,140
-$130,760 QoQ
Shares Held
60,576
-3.2% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. NAGE ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in NAGE
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $267,140 | 60,576 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $397,900 | 62,563 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $683,002 | 73,205 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,085,591 | 75,336 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $465,198 | 67,420 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $297,142 | 55,959 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $150,219 | 41,156 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $124,266 | 45,519 | Shares | Sole | 2024-08-01 | |
| 2022-03-31 | $115,740 | 47,049 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $173,569 | 46,409 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $293,153 | 46,755 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $444,735 | 45,105 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $432,404 | 46,296 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $228,268 | 47,556 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $178,549 | 44,526 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $236,642 | 51,556 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $156,101 | 47,884 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||